News & Trends - MedTech & Diagnostics
Medtech company enters ‘patient-focused’ partnership on diabetes data sharing technology

MedTech News: The evolution of mobile technology provides a large number of health-related smartphone apps, aiming to increase the self-management skills of the patient in chronic diseases, to facilitate the communication between the patient and healthcare providers, and to increase also the patient’s adherence to therapy.
Terumo, a global medtech company, and Glooko, a global leader in data management, remote patient monitoring and mobile apps for people with chronic conditions, have announced a technology integration to deliver new diabetes data sharing solutions together globally.
This new integration will enable people with diabetes to transfer recorded data from MEDISAFE WITH insulin patch pump into the Glooko platform, thus helping them to visualise insulin dosage, food, and activities in graphs more easily and to realise personalised remote patient monitoring and patient care more effectively.
Available in Europe from May 2022, the two companies will start offering this new diabetes data solution, enabling patients to share their data while with healthcare professionals and also remotely from home. This integration will allow healthcare professionals to view the patient’s latest health records more frequently, in-person at the clinic or remotely via Glooko’s analytics portal.
“We are excited to announce this new patient-focused collaboration with Glooko. These new solutions will allow people with diabetes to upload their data from home easily without the need to visit the hospital. We believe this is a valuable solution for both patients and healthcare providers especially in the post COVID-19 ‘new normal’ lifestyle,” commented Hikaru Samejima, President of Terumo’s General Hospital Company.
You may also like: Urologists and PCFA welcome Medicare funding of game-changing prostate cancer scan
Russ Johannesson, Chief Executive Officer for Glooko, stated “Our continued partnership with Terumo means even more access to health data for people with diabetes and their healthcare providers. We are very pleased to expand our partnership with Terumo by integrating Glooko’s data management and remote patient monitoring platform with the MEDISAFE WITH insulin patch pump. This means people with diabetes will be able to make more informed decisions with their data, and collaborate with their health care team. That data includes insulin, glucose, diet, activity and blood pressure. Having the best connectivity is imperative for delivering world class care, so we are happy to partner with Terumo to integrate its new insulin patch pump.”
The Health Industry Hub news and professional development content are copyright protected and access is provided under individual user licenses.
Visit https://www.healthindustryhub.com.au/membership/ and T&Cs for more information.
Digital & Innovation

Reimagining remote care with Australia’s first virtual hospital
Australia’s first virtual hospital is taking on a new role as a national testbed for advancing the future of patient-facing […]
MoreNews & Trends - MedTech & Diagnostics

Health Minister and Opposition face off at the National Press Club
In a blistering showdown at the National Press Club, Federal Health Minister, Mark Butler, and his Opposition counterpart Senator Anne […]
MoreNews & Trends - Pharmaceuticals

GSK nabs label expansion for RSV vaccine
Coinciding with World Immunisation Week (24-30 April), GSK has secured TGA approval for its respiratory syncytial virus (RSV) vaccine, marking […]
MoreNews & Trends - MedTech & Diagnostics

Low-value imaging linked to high human cost
Imagining has become a cornerstone of modern medicine, for their ability to detect cancers, guide surgeries, and uncover internal injuries […]
More